Ontology highlight
ABSTRACT: Background/aims
Pancreatic ductal adenocarcinoma (PDA) is associated with an extremely poor prognosis. This study assessed the genetic diversity among patients with PDA and compared their mutational profiles before and after treatment.Methods
Tumors and matched blood samples were obtained from 22 PDA patients treated with neoadjuvant chemoradiation therapy. The somatic mutations were analyzed with comprehensive cancer gene panel (CCP). In addition, the biopsy samples obtained at diagnosis and the surgically resected samples after treatment were compared for seven patients. The CCP provided formalin-fixed paraffin-embedded sample-compatible multiplexed target selection for 409 genes implicated in cancer.Results
Assessments of the MLH1, MLH3, MSH2
SUBMITTER: Yoon KA
PROVIDER: S-EPMC6860036 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature